The American Journal of Managed Care

Long-Term Data Show Favorable Survival Outcomes With G-Clb in Treatment-Naive CLL

Obinutuzumab combined with chlorambucil showed superior overall survival compared to rituximab in the CLL11 trial. Obinutuzumab's glycoengineered type II CD20 antibody design contributes to its ...
Healio

Cognitive outcomes improved with endovascular therapy in acute ischemic stroke

Please provide your email address to receive an email when new articles are posted on . Researchers engaged in a secondary analysis of the ESCAPE clinical trial in patients with acute ischemic stroke.
Healio

Favorable outcomes after HCT for sickle cell disease can guide shared decision-making

Please provide your email address to receive an email when new articles are posted on . Ninety percent of patients with sickle cell disease survived at least 7 years after allogeneic HCT. A majority ...
ascopubs.org

Paclitaxel, Ifosfamide, and Cisplatin as Initial Salvage Chemotherapy for Germ Cell Tumors: Long-Term Follow-Up and Outcomes for Favorable- and Unfavorable-Risk Disease

Genetic Counseling, Testing, and Family Communication Into Survivorship After Diagnosis of Breast Cancer Patients with GCT who received TIP after cisplatin-based chemotherapy were eligible. Favorable ...